The Clinical Trials Advisory Committee (CTAC) was formed in 2014 to provide advice to the Department of Health and the Department of Industry and Science on various measures under the clinical trials reform initiative.
Membership of the group is drawn from senior representatives from Commonwealth and State Governments, industry, academic trials and consumer groups. ACTA is represented on CTAC by Interim Chair, Professor John Zalcberg.
To read more about CTAC, view members of the committee and read communiqué from CTAC meetings, including the latest release communiqué from the November 2014 meeting, visit the Dept of Industry and Science website.